L
Lajos Raduly
Researcher at Iuliu Hațieganu University of Medicine and Pharmacy
Publications - 40
Citations - 1253
Lajos Raduly is an academic researcher from Iuliu Hațieganu University of Medicine and Pharmacy. The author has contributed to research in topics: Cancer & microRNA. The author has an hindex of 13, co-authored 28 publications receiving 673 citations. Previous affiliations of Lajos Raduly include University of Agricultural Sciences, Dharwad.
Papers
More filters
Journal ArticleDOI
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer.
Cornelia Braicu,Mihail Buse,Constantin Ioan Busuioc,Rares Drula,Diana Gulei,Lajos Raduly,Alexandru Rusu,Alexandru Irimie,Atanas G. Atanasov,Ondrej Slaby,Calin Ionescu,Ioana Berindan-Neagoe +11 more
TL;DR: New insights are discussed into MAPK as a complex cell signaling pathway with roles in the sustenance of cellular normal conduit, response to cancer therapy, and activation of compensatory pathways.
Journal ArticleDOI
Overview upon miR-21 in lung cancer: focus on NSCLC
Cecilia Bica-Pop,Roxana Cojocneanu-Petric,Lorand Magdo,Lajos Raduly,Diana Gulei,Ioana Berindan-Neagoe +5 more
TL;DR: The mechanisms of action of miR-21 in cancer and the associated changes upon tumor cells are reviewed together a focused perspective on NSCLC signaling, prognosis and therapy.
Journal ArticleDOI
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression.
Diana Gulei,Lorand Magdo,Ancuta Jurj,Lajos Raduly,Lajos Raduly,Roxana Cojocneanu-Petric,Alin Moldovan,Cristian Moldovan,Adrian Florea,Sergiu Pasca,Laura-Ancuta Pop,Vlad Moisoiu,Liviuta Budisan,Cecilia Pop-Bica,Cristina Ciocan,Rares Buiga,Mihai-Stefan Muresan,Rares Stiufiuc,Calin Ionescu,Ioana Berindan-Neagoe +19 more
TL;DR: The proposed strategy is aiming towards inhibition of metastasis and limitation of the tumor borders in advanced stages patients in order to prolong the survival time and to increase the efficiency of the current therapeutic strategies.
Journal ArticleDOI
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers
Roxana Cojocneanu Petric,Cornelia Braicu,Lajos Raduly,Oana Zanoaga,Nicolae Dragoş,Paloma Monroig,Dan L. Dumitrascu,Ioana Berindan-Neagoe +7 more
TL;DR: The importance of improving dietary choices as a chemo-preventive strategy is exalted, since ongoing studies continue to prove effective.
Journal ArticleDOI
SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancer.
Vlad Moisoiu,Vlad Moisoiu,Andrei Stefancu,Andrei Stefancu,Diana Gulei,Radu Boitor,Lorand Magdo,Lajos Raduly,Lajos Raduly,Sergiu Pasca,Paul Kubelac,Nikolay Mehterov,Vasile Chiș,Marioara Simon,Maria Muresan,Alexandra Iulia Irimie,Mihaela Baciut,Rares Stiufiuc,Ioana E. Pavel,Ioana E. Pavel,Patriciu Achimas-Cadariu,Calin Ionescu,Vladimir Lazar,Victoria Sarafian,Ioan Notingher,Nicolae Leopold,Nicolae Leopold,Ioana Berindan-Neagoe +27 more
TL;DR: SERS on serum represents a promising strategy of diagnosing cancer which can discriminate between cancer patients and controls, as well as between cancer types such as breast, colorectal, lung ovarian and oral cancer.